Monthly Archives: April 2016

Vitamin D is increasingly recognized as a potential immune regulator of multiple sclerosis disease activity but its impact on B lymphocytes remains ill-defined. The authors of this study assessed the impact of vitamin D on B-cell proliferation and cytokine secretion and … Continue reading →

The G/C single-nucleotide polymorphism in the serotonin 1a receptor promoter, rs6295, has previously been linked with depression, suicide and antidepressant responsiveness. In vitro studies suggest that rs6295 may have functional effects on the expression of the serotonin 1a receptor gene … Continue reading →

“Applying well-established psychological paradigms to our closest relatives represents a promising approach for providing insight into similarities and differences between humans and apes. Numerous articles have been published on the dot-probe task, showing that humans have an attentional bias toward … Continue reading →

Vortioxetine is a multimodal antidepressant that acts as a serotonin (5-HT)3, 5-HT7, and 5-HT1D receptor antagonist; 5-HT1B receptor partial agonist; 5-HT1A receptor agonist; and 5-HT transporter inhibitor in vitro. In preclinical and clinical studies vortioxetine has shown positive effects on … Continue reading →